Home Medical Devices Continuous Glucose Monitoring Systems Market Size, Demand, CAGR of 21.2%, Forecast to 203

Continuous Glucose Monitoring Systems Market Size, Share & Trends Analysis Report By Component (Transmitters, Receivers, Sensors), By Demographics (Child Population (<=14 Years), Adult Population (>14 Years)), By End User (Hospitals, Homecare Settings) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2023-2031

Report Code: SRMD909DR
Last Updated : December 06, 2024
Author : Debashree Bora
Starting From
USD 2300
Buy Now

Table Of Content

  1. Executive Summary

    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends

    1. Global Continuous Glucose Monitoring Systems Market Introduction
    2. By Component
      1. Introduction
        1. Component By Value
      2. Transmitters
        1. By Value
      3. Receivers
        1. By Value
      4. Sensors
        1. By Value
    3. By Demographics
      1. Introduction
        1. Demographics By Value
      2. Child Population (<=14 Years)
        1. By Value
      3. Adult Population (>14 Years)
        1. By Value
    4. By End User
      1. Introduction
        1. End User By Value
      2. Hospitals
        1. By Value
      3. Homecare Settings
        1. By Value
    1. Introduction
    2. By Component
      1. Introduction
        1. Component By Value
      2. Transmitters
        1. By Value
      3. Receivers
        1. By Value
      4. Sensors
        1. By Value
    3. By Demographics
      1. Introduction
        1. Demographics By Value
      2. Child Population (<=14 Years)
        1. By Value
      3. Adult Population (>14 Years)
        1. By Value
    4. By End User
      1. Introduction
        1. End User By Value
      2. Hospitals
        1. By Value
      3. Homecare Settings
        1. By Value
    5. U.S.
      1. By Component
        1. Introduction
          1. Component By Value
        2. Transmitters
          1. By Value
        3. Receivers
          1. By Value
        4. Sensors
          1. By Value
      2. By Demographics
        1. Introduction
          1. Demographics By Value
        2. Child Population (<=14 Years)
          1. By Value
        3. Adult Population (>14 Years)
          1. By Value
      3. By End User
        1. Introduction
          1. End User By Value
        2. Hospitals
          1. By Value
        3. Homecare Settings
          1. By Value
    6. Canada
    1. Introduction
    2. By Component
      1. Introduction
        1. Component By Value
      2. Transmitters
        1. By Value
      3. Receivers
        1. By Value
      4. Sensors
        1. By Value
    3. By Demographics
      1. Introduction
        1. Demographics By Value
      2. Child Population (<=14 Years)
        1. By Value
      3. Adult Population (>14 Years)
        1. By Value
    4. By End User
      1. Introduction
        1. End User By Value
      2. Hospitals
        1. By Value
      3. Homecare Settings
        1. By Value
    5. U.K.
      1. By Component
        1. Introduction
          1. Component By Value
        2. Transmitters
          1. By Value
        3. Receivers
          1. By Value
        4. Sensors
          1. By Value
      2. By Demographics
        1. Introduction
          1. Demographics By Value
        2. Child Population (<=14 Years)
          1. By Value
        3. Adult Population (>14 Years)
          1. By Value
      3. By End User
        1. Introduction
          1. End User By Value
        2. Hospitals
          1. By Value
        3. Homecare Settings
          1. By Value
    6. Germany
    7. France
    8. Spain
    9. Italy
    10. Russia
    11. Nordic
    12. Benelux
    13. Rest of Europe
    1. Introduction
    2. By Component
      1. Introduction
        1. Component By Value
      2. Transmitters
        1. By Value
      3. Receivers
        1. By Value
      4. Sensors
        1. By Value
    3. By Demographics
      1. Introduction
        1. Demographics By Value
      2. Child Population (<=14 Years)
        1. By Value
      3. Adult Population (>14 Years)
        1. By Value
    4. By End User
      1. Introduction
        1. End User By Value
      2. Hospitals
        1. By Value
      3. Homecare Settings
        1. By Value
    5. China
      1. By Component
        1. Introduction
          1. Component By Value
        2. Transmitters
          1. By Value
        3. Receivers
          1. By Value
        4. Sensors
          1. By Value
      2. By Demographics
        1. Introduction
          1. Demographics By Value
        2. Child Population (<=14 Years)
          1. By Value
        3. Adult Population (>14 Years)
          1. By Value
      3. By End User
        1. Introduction
          1. End User By Value
        2. Hospitals
          1. By Value
        3. Homecare Settings
          1. By Value
    6. Korea
    7. Japan
    8. India
    9. Australia
    10. Taiwan
    11. South East Asia
    12. Rest of Asia-Pacific
    1. Introduction
    2. By Component
      1. Introduction
        1. Component By Value
      2. Transmitters
        1. By Value
      3. Receivers
        1. By Value
      4. Sensors
        1. By Value
    3. By Demographics
      1. Introduction
        1. Demographics By Value
      2. Child Population (<=14 Years)
        1. By Value
      3. Adult Population (>14 Years)
        1. By Value
    4. By End User
      1. Introduction
        1. End User By Value
      2. Hospitals
        1. By Value
      3. Homecare Settings
        1. By Value
    5. UAE
      1. By Component
        1. Introduction
          1. Component By Value
        2. Transmitters
          1. By Value
        3. Receivers
          1. By Value
        4. Sensors
          1. By Value
      2. By Demographics
        1. Introduction
          1. Demographics By Value
        2. Child Population (<=14 Years)
          1. By Value
        3. Adult Population (>14 Years)
          1. By Value
      3. By End User
        1. Introduction
          1. End User By Value
        2. Hospitals
          1. By Value
        3. Homecare Settings
          1. By Value
    6. Turkey
    7. Saudi Arabia
    8. South Africa
    9. Egypt
    10. Nigeria
    11. Rest of MEA
    1. Introduction
    2. By Component
      1. Introduction
        1. Component By Value
      2. Transmitters
        1. By Value
      3. Receivers
        1. By Value
      4. Sensors
        1. By Value
    3. By Demographics
      1. Introduction
        1. Demographics By Value
      2. Child Population (<=14 Years)
        1. By Value
      3. Adult Population (>14 Years)
        1. By Value
    4. By End User
      1. Introduction
        1. End User By Value
      2. Hospitals
        1. By Value
      3. Homecare Settings
        1. By Value
    5. Brazil
      1. By Component
        1. Introduction
          1. Component By Value
        2. Transmitters
          1. By Value
        3. Receivers
          1. By Value
        4. Sensors
          1. By Value
      2. By Demographics
        1. Introduction
          1. Demographics By Value
        2. Child Population (<=14 Years)
          1. By Value
        3. Adult Population (>14 Years)
          1. By Value
      3. By End User
        1. Introduction
          1. End User By Value
        2. Hospitals
          1. By Value
        3. Homecare Settings
          1. By Value
    6. Mexico
    7. Argentina
    8. Chile
    9. Colombia
    10. Rest of LATAM
    1. Continuous Glucose Monitoring Systems Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Pfizer Inc.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Baxter International Inc.
    3. Senseonics
    4. Dexcom Inc.
    5. Abbott Laboratories
    6. Nemaura Medical Inc.
    7. Medtronic Inc.
    8. Medtrum Technologies Inc.
    9. Animas Corporation
    10. Tandem Diabetes Care
    11. Novo Nordisk
    12. Ypsomed
    13. GlySens
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
Market Overview The global continuous blood glucose monitoring market size was valued at USD 5.25 billion in 2021. It is projected to reach USD 14.92 billion by 2030, growing at a CAGR of 12.3% during the forecast period (2022-2030). The blood gluc
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report


We are featured on :